Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Defense
- Branch
- Navy
- Recipient company
- LUNA INNOVATIONS INCORPORATED
- Proposal award date
- 2006-08-23
- Contract end date
- 2007-05-23
- UEI
- SJHFCDGKJJC5
- Solicitation number
- 2006.1
- Topic code
- N06-075
Research abstract
Steam sterilization, or autoclaving, is the preferred method for eliminating the risk of cross infection through contaminated instruments and the only one recommended throughout the world by healthcare professionals including the W.H.O. (World Healthcare Organization) and C.D.C. (Center of Disease Control). At a pressure of 2 atmospheres, recommended temperatures for steam autoclave specifications is 121„aC in the US and 134„aC in Europe. Unfortunately, the ability to generate these levels of pressure and temperature are currently dependent on the availability of electrical power, which can be problematic for military hospitals in austere environments. Luna Innovations proposes to develop a system capable of effectively sterilizing medical instruments with or without electrical power. The focus of the Phase I program will be to demonstrate effective generation of pressure and temperature to sterilize contaminated material without electrical power. During the Phase II of the program, Luna will develop a full-scale integrated solid-state steam autoclave system for operation with or without electrical power. Luna has assembled the highly qualified, multidisciplinary team required for a successful program and has a history of bringing novel research from the laboratory to commercial markets. BENEFITS: Decontamination and sterilization of medical equipment in austere environments is vitally important in military hospitals. Luna¡¦s proposed system addresses this need with a multi-mode steam sterilizater that is not dependent on electrical power. This system is effective as a non-destructive, non-toxic method for sterilization in commercial applications such as pharmaceutical, medical, dental, food, and military activities of concern to civilian lives and national security. This system will be able to fulfill the sterilization needs during threats of biological warfare during power outages that might occur during such emergencies. It is possible that the developed system can be independent from solid-state sterilization systems and be portable for individual use and included in current first aid kits.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
994 SBIR/STTR records share this UEI (1991–2026). Reported award amounts total $336,438,763. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Energy, Department of Health and Human Services, National Science Foundation, Environmental Protection Agency
Agency intelligence
Department of Defense
Back to SBIR/STTR Research Awards